Enveric Biosciences Inc (ENVB)

May 19, 2026

Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003 - Investing News Network

May 19, 2026

May 19, 2026

Enveric Biosciences (ENVB) Achieves Key Milestone in Neuropsychi - GuruFocus

May 19, 2026

May 17, 2026

Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026 - BioSpace

May 17, 2026

May 15, 2026

Enveric Biosciences Inc (ENVB) Stock Price, Quote, News & History - Benzinga

May 15, 2026

May 15, 2026

Enveric Biosciences (ENVB) affiliates report 158,732 warrants; Easton 161,232 - Stock Titan

May 15, 2026

May 15, 2026

Enveric (ENVB) Secures $13.9 Million in Private Placement Fundin - GuruFocus

May 15, 2026

May 15, 2026

Enveric (ENVB) Advances in Mental Health Therapeutics Developmen - GuruFocus

May 15, 2026

May 15, 2026

Enveric Biosciences Reports Q1 2026 Results, Advances Non-Hallucinogenic Antidepressant EB-003 Toward Clinical Trials - Minichart

May 15, 2026

May 15, 2026

Enveric Biosciences Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026

May 15, 2026

Enveric Biosciences (NASDAQ: ENVB) posts Q1 2026 loss and flags going concern risk - Stock Titan

May 15, 2026

May 15, 2026

Enveric Biosciences (ENVB) advances EB-003 and boosts cash in Q1 2026 - Stock Titan

May 15, 2026

May 14, 2026

What's going on with Enveric Biosciences stock on Friday? - MSN

May 14, 2026

May 13, 2026

Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders - Investing News Network

May 13, 2026

May 13, 2026

Enveric highlights preclinical PTSD data amid rising focus on mental health therapies - MSN

May 13, 2026

May 13, 2026

Enveric Biosciences receives patent for psilocybin derivatives By Investing.com - Investing.com Canada

May 13, 2026

May 13, 2026

Enveric Biosciences (ENVB) Expands Patent Portfolio with New Psi - GuruFocus

May 13, 2026

May 12, 2026

Enveric Biosciences Stock Short Interest Rises to 45.7% - Moomoo

May 12, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 09, 2026

MSN Money - MSN

May 09, 2026

May 08, 2026

Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

May 08, 2026

May 08, 2026

ENVB Stock Price, Quote & Chart | ENVERIC BIOSCIENCES INC (NASDAQ:ENVB) - ChartMill

May 08, 2026

May 05, 2026

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model - Investing News Network

May 05, 2026

May 05, 2026

Enveric Biosciences IncReports positive preclinical results for EB-003 in PTSD model - marketscreener.com

May 05, 2026

May 05, 2026

Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health TherapiesEnveric Bioscienc - Benzinga

May 05, 2026

May 03, 2026

Enveric Biosciences surges over 90%, other psychedelic stocks soar in Monday pre-market: What's going on? - MSN

May 03, 2026

Apr 30, 2026

Enveric Biosciences Corrects Reverse Stock Split Proxy Disclosure - TipRanks

Apr 30, 2026

Apr 30, 2026

Enveric Biosciences (ENVB) clarifies 1‑for‑15 max reverse split in 2026 proxy - Stock Titan

Apr 30, 2026

Apr 30, 2026

Enveric Biosciences | EFFECT: Others - Moomoo

Apr 30, 2026

Apr 29, 2026

Enveric Biosciences (NASDAQ: ENVB) files resale prospectus for 6.82M shares - Stock Titan

Apr 29, 2026

Apr 28, 2026

Lakewood-Amedex appoints Enveric CEO to board of directors - Investing.com UK

Apr 28, 2026

Apr 28, 2026

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors - Investing News Network

Apr 28, 2026

Apr 28, 2026

Lakewood-Amedex appoints Enveric CEO to board of directors By Investing.com - Investing.com Nigeria

Apr 28, 2026